Menu

NYU Medical School Is Now Free, Almost

All students’ tuition will be funded through its endowment.

Aug 17, 2018
Shawna Williams

ABOVE: WIKIMEDIA, KENNETH WILSEY

In a surprise announcement made at the end of the school’s annual white coat ceremony for new medical students on Thursday (August 16), the chair of the board of trustees for New York University School of Medicine declared that all students will now attend tuition-free. The change will save current and future students approximately $55,000 per year.

“It makes an enormous difference in our students[’] lives,” Robert Grossman, a dean at the school and CEO of NYU Langone Health, tell STAT News. “We think it will, at some level, relieve one source of stress in medical training.”

Tuition will be paid through an endowment that now sits at $450 million, STAT reports; the school is continuing to fundraise with hopes of bringing it to $600 million. Students will still be on the hook for about $27,000 per year in room, board, and fees, The New York Times notes.

NYU is the first top-10 ranked medical school in the US to offer free tuition, according to the school’s announcement. The Association of American Medical Colleges has found that 75 percent of medical students graduate with education debt—an average of more than $190,000 each.

“[O]ur hope—and expectation—is that by making medical school accessible to a broader range of applicants, we will be a catalyst for transforming medical education nationwide,” says Kenneth Langone, chair of the Board of Trustees of NYU Langone Health, in the school’s statement.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.